Open call TRANSVAC 2 TRAINING

Keen on furthering your skills in vaccine development? 📢Open call for #TRANSVAC2 #training! FREE training from experts in the field! 💥 Three courses are open for applications: ✔M3 #Adjuvants and...

BLOOD-ON-CHIP INITIATIVE

BIOASTER and Institut Pasteur are proud to join forces to build a novel microphysiological system (MPS) mimicking the first steps of immune activation during vaccination. This system will enable studying...

New publication – Science Translational Medicine

“The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance” Dr Gilles Courtemanche, BIOASTER Antimicrobials Program Head is co-author of a scientific publication...

DxPX Conference support to the Virtual US event in July

BIOASTER is proud to support DxPx Conference Industry & Investor Conference, the unique international partnering conference with focus on #diagnostics, #PrecisionMedicine & research tools. During the virtual US event from July 27th – 31st, 2021, Xavier Morge,...

New collaboration with PiLeJe Laboratoire

PiLeJe Laboratoire to collaborate with BIOASTER to investigate the health potential of a probiotic selection Pileje Laboratoire, a French company leader in probiotic-based dietary supplements in Europe and specialized in...

Antimicrobials Program Highlights 2020

Hopefully, we will have a chance to share updates face to face, in the meantime we are happy to highlight some of the 2020 Antimicrobials Program achievements. If this should...

Open Call: Apply for TRANSVAC2 Vaccine Development Services

Open Call: Apply for TRANSVAC2 Vaccine Development Services Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at...

BIOASTER & GENCOVERY

BIOASTER first shareholder with its two co-founders Adama OUATTARA and Wassim ABOU-JAOUDE of Gencovery. Wishing success to the first BIOASTER start-up. Gencovery provides cutting-edge software based on digital organisms for...

Discover our new @BIOASTER publication in @NatureProtocols.

A droplet #microfluidics technology has been developed to measure #proteinsecretion kinetics from #singlecells. This technology has been successfully used to characterize monocyte anergy in septic shock patients. SharedIt link